Overview
Safety and Efficacy Study to Treat Bacterial Vaginosis
Status:
Completed
Completed
Trial end date:
2012-12-01
2012-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to determine if product 55394 is safe and efficacious for the treatment of bacterial vaginosis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Medicis Global Service Corporation
Criteria
Inclusion Criteria:- Have a clinical diagnosis of bacterial vaginosis as determined by the investigator.
- Other items as identified in the protocol.
Exclusion Criteria:
- Have a known or suspected other infectious cause of vulvovaginitis.
- Other items as identified in the protocol.